STAT Brand Studio
@statbrandstudio.bsky.social
Our award-winning team creates custom content that inspires, engages, and informs the STAT News audience in medicine, health care, and the life sciences.
Genentech, *the* original biotech company, is celebrating its 50th anniversary in 2026. VP, US External Affairs Joy Russell stopped by the STAT Brand Studio multimedia lounge at #statsummit to talk with Britt Whitmore about the company's past, present, future, and its patient impact.
October 24, 2025 at 5:46 PM
Genentech, *the* original biotech company, is celebrating its 50th anniversary in 2026. VP, US External Affairs Joy Russell stopped by the STAT Brand Studio multimedia lounge at #statsummit to talk with Britt Whitmore about the company's past, present, future, and its patient impact.
Reposted by STAT Brand Studio
STAT is 10!
Join us in reflecting on a decade of reporting from the frontiers of health and medicine.
We’re proud that since 2015 we’ve delivered urgent, authoritative, and impactful journalism.
Celebrate with us: www.statnews.com/stat-10th-an...
#STAT10 🧵
Join us in reflecting on a decade of reporting from the frontiers of health and medicine.
We’re proud that since 2015 we’ve delivered urgent, authoritative, and impactful journalism.
Celebrate with us: www.statnews.com/stat-10th-an...
#STAT10 🧵
STAT 10 Year Anniversary
When we named ourselves “STAT’’ 10 years ago, we conceded, “It takes a bit of chutzpah to name a digital-age life-sciences publication after a buzzword
www.statnews.com
September 9, 2025 at 1:00 PM
STAT is 10!
Join us in reflecting on a decade of reporting from the frontiers of health and medicine.
We’re proud that since 2015 we’ve delivered urgent, authoritative, and impactful journalism.
Celebrate with us: www.statnews.com/stat-10th-an...
#STAT10 🧵
Join us in reflecting on a decade of reporting from the frontiers of health and medicine.
We’re proud that since 2015 we’ve delivered urgent, authoritative, and impactful journalism.
Celebrate with us: www.statnews.com/stat-10th-an...
#STAT10 🧵
As global biotech competition intensifies and new R&D centers emerge, Boston faces a pivotal moment. Can it continue to lead the world in life sciences?
Join us for an in-person event in Cambridge, MA next month to find out!
www.statnews.com/event/local-...
Join us for an in-person event in Cambridge, MA next month to find out!
www.statnews.com/event/local-...
August 14, 2025 at 6:21 PM
As global biotech competition intensifies and new R&D centers emerge, Boston faces a pivotal moment. Can it continue to lead the world in life sciences?
Join us for an in-person event in Cambridge, MA next month to find out!
www.statnews.com/event/local-...
Join us for an in-person event in Cambridge, MA next month to find out!
www.statnews.com/event/local-...
At #STATBreakthrough Summit West, SBS spoke with Boston Scientific’s CMO about 3 AI use cases in cardiology — from scaling ECG data to spotting heart failure early.
We also discussed the intersection of evidence-based medicine and AI:
www.statnews.com/sponsor/2025...
@statnews.com #cardiology
We also discussed the intersection of evidence-based medicine and AI:
www.statnews.com/sponsor/2025...
@statnews.com #cardiology
July 7, 2025 at 2:57 PM
At #STATBreakthrough Summit West, SBS spoke with Boston Scientific’s CMO about 3 AI use cases in cardiology — from scaling ECG data to spotting heart failure early.
We also discussed the intersection of evidence-based medicine and AI:
www.statnews.com/sponsor/2025...
@statnews.com #cardiology
We also discussed the intersection of evidence-based medicine and AI:
www.statnews.com/sponsor/2025...
@statnews.com #cardiology
Reposted by STAT Brand Studio
STAT is going to #ASCO25!
STAT reporters will be on the ground, delivering breaking oncology news and insights to help you stay ahead.
Here’s how to follow our coverage and connect with us during ASCO.
Explore all our offerings here: www.statnews.com/asco-2025/
STAT reporters will be on the ground, delivering breaking oncology news and insights to help you stay ahead.
Here’s how to follow our coverage and connect with us during ASCO.
Explore all our offerings here: www.statnews.com/asco-2025/
STAT@ASCO 2025
ASCO 2025: The Latest in Cancer Research The ASCO annual meeting is widely considered one of the largest and most prestigious cancer research conferences
www.statnews.com
May 23, 2025 at 5:58 PM
STAT is going to #ASCO25!
STAT reporters will be on the ground, delivering breaking oncology news and insights to help you stay ahead.
Here’s how to follow our coverage and connect with us during ASCO.
Explore all our offerings here: www.statnews.com/asco-2025/
STAT reporters will be on the ground, delivering breaking oncology news and insights to help you stay ahead.
Here’s how to follow our coverage and connect with us during ASCO.
Explore all our offerings here: www.statnews.com/asco-2025/
SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases
www.statnews.com/event/rare-a...
www.statnews.com/event/rare-a...
May 9, 2025 at 7:13 PM
SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases
www.statnews.com/event/rare-a...
www.statnews.com/event/rare-a...
SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases
www.statnews.com/event/rare-a...
www.statnews.com/event/rare-a...
May 9, 2025 at 7:11 PM
SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases
www.statnews.com/event/rare-a...
www.statnews.com/event/rare-a...
Expanding the scope of innovation is key to unlocking progress in health care. This STAT Brand Studio event will examine how a holistic approach to innovation is reshaping the development and delivery of solutions to benefit patients.
Join us live tomorrow!
Join us live tomorrow!
Virtual Event | Rethinking Innovation for Patients with Rare and Complex Chronic Diseases
Join STAT and Takeda on March 25 to explore how plasma-derived therapies are reshaping health care. Register now for this virtual event.
www.statnews.com
March 24, 2025 at 5:57 PM
Expanding the scope of innovation is key to unlocking progress in health care. This STAT Brand Studio event will examine how a holistic approach to innovation is reshaping the development and delivery of solutions to benefit patients.
Join us live tomorrow!
Join us live tomorrow!
Biotherapeutic discovery has a low success rate, but Genentech aims to speed up and scale this process by using AI to transform the traditional, sequential drug discovery model into a cyclical and iterative one.
A new, iterative model of drug discovery using AI
After its founding in 1976, scientists at Genentech worked methodically toward the development of its first biotechnology product. It was nearly a decade
buff.ly
January 14, 2025 at 2:48 PM
Biotherapeutic discovery has a low success rate, but Genentech aims to speed up and scale this process by using AI to transform the traditional, sequential drug discovery model into a cyclical and iterative one.
Over the past two years, City of Hope has significantly expanded, transforming cancer care and improving patient access. At the STAT Summit, Marcel van den Brink, M.D., Ph.D., highlighted their clinical trial network, novel therapies, and research on the microbiome's role in immune response.
January 7, 2025 at 2:48 PM
Over the past two years, City of Hope has significantly expanded, transforming cancer care and improving patient access. At the STAT Summit, Marcel van den Brink, M.D., Ph.D., highlighted their clinical trial network, novel therapies, and research on the microbiome's role in immune response.
Colorectal cancer remains the 2nd leading cause of cancer deaths, with disparities in screening and care access posing major challenges. At the 2024 STAT Summit, Dr. Angie Nicholas and Dr. Fola May discussed how data and collaboration is driving efforts to close these gaps.
Fighting colorectal cancer disparities with real-world data
STAT Brand Studio · Episode
buff.ly
January 2, 2025 at 8:31 PM
Colorectal cancer remains the 2nd leading cause of cancer deaths, with disparities in screening and care access posing major challenges. At the 2024 STAT Summit, Dr. Angie Nicholas and Dr. Fola May discussed how data and collaboration is driving efforts to close these gaps.
“I think this personalized pathway is what we’re really driving towards…”
Hear more from Dr. Joan Cangiarella, Elaine Langone Professor of Pathology at the NYU Grossman School of Medicine and Senior Associate Dean for Education, Faculty, and Academic Affairs at @nyulangone.
Hear more from Dr. Joan Cangiarella, Elaine Langone Professor of Pathology at the NYU Grossman School of Medicine and Senior Associate Dean for Education, Faculty, and Academic Affairs at @nyulangone.
December 10, 2024 at 5:04 PM
“I think this personalized pathway is what we’re really driving towards…”
Hear more from Dr. Joan Cangiarella, Elaine Langone Professor of Pathology at the NYU Grossman School of Medicine and Senior Associate Dean for Education, Faculty, and Academic Affairs at @nyulangone.
Hear more from Dr. Joan Cangiarella, Elaine Langone Professor of Pathology at the NYU Grossman School of Medicine and Senior Associate Dean for Education, Faculty, and Academic Affairs at @nyulangone.
Dr. Joan Cangiarella is the Sr. Associate Dean for Education, Faculty, and Academic Affairs at NYU Langone Health, one of the nation’s premier academic medical centers and health systems. She describes how NYU Langone is transforming medical education in a @statbrandstudio.bsky.social podcast:
December 6, 2024 at 5:23 PM
Dr. Joan Cangiarella is the Sr. Associate Dean for Education, Faculty, and Academic Affairs at NYU Langone Health, one of the nation’s premier academic medical centers and health systems. She describes how NYU Langone is transforming medical education in a @statbrandstudio.bsky.social podcast: